ESRD (END STAGE RENAL DISEASE)
Clinical trials for ESRD (END STAGE RENAL DISEASE) explained in plain language.
Never miss a new study
Get alerted when new ESRD (END STAGE RENAL DISEASE) trials appear
Sign up with your email to follow new studies for ESRD (END STAGE RENAL DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pig kidney trial offers new hope for kidney failure patients
Disease control Recruiting nowThis study tests a genetically modified pig kidney (called the 10 GE Xenokidney) in 50 adults with end-stage kidney disease who cannot get a human kidney transplant or face a long wait. The goal is to see if the pig kidney works safely and well, helping people live longer and imp…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
New drug AP301 aims to tame dangerous phosphate levels in dialysis patients
Disease control Recruiting nowThis phase 3 trial tests whether AP301 can safely lower high blood phosphate levels in people with end-stage kidney disease who are on dialysis. About 264 participants will receive either AP301 or a low-dose comparator for 8 weeks, then all receive AP301 for 24 weeks. The study m…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Pig kidney transplants begin in humans: a lifeline for those who Can't get a human donor?
Disease control Recruiting nowThis study tests whether a specially modified pig kidney (called a thymokidney) can safely work in people with end-stage kidney disease who cannot get a human kidney transplant. About 50 participants will receive the pig kidney and be followed for life to check survival, kidney f…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC